North Macedonia vs Trinidad and Tobago: Share of adolescent girls vaccinated against human papillomavirus
North Macedonia
21.0%
in 2024
Trinidad and Tobago
16.0%
in 2024
North Macedonia rank
67th
Trinidad and Tobago rank
68th
Share of adolescent girls vaccinated against human papillomavirus over time
- North Macedonia
- Trinidad and Tobago
How they compare
North Macedonia currently reports 21.0% against 16.0% in Trinidad and Tobago, a difference of 5.0%.
That makes North Macedonia's figure about 1.3 times Trinidad and Tobago's.
Across all 6 years both countries report, North Macedonia has been ahead every year.
North Macedonia ranks 67th and Trinidad and Tobago ranks 68th of 74 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.0% | 6.0% | 42.0% | North Macedonia |
| 2020s | 35.0% | 11.4% | 23.6% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, North Macedonia or Trinidad and Tobago?
- North Macedonia, at 21.0% against 16.0% in Trinidad and Tobago as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between North Macedonia and Trinidad and Tobago?
- 5.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Trinidad and Tobago?
- 6 years are reported by both, from 2019 to 2024.
- How do North Macedonia and Trinidad and Tobago rank globally for share of adolescent girls vaccinated against human papillomavirus?
- North Macedonia ranks 67th and Trinidad and Tobago ranks 68th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.